| Cryo-Cell International is engaged in cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacture of PrepaCyte® CB Processing System units, the processing technology used to process umbilical cord blood stem cells and cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. Co. stores cord blood and cord tissue specimens for the benefit of newborn babies and possibly other members of their families. Co. also provides cord tissue service, which stores a section of the umbilical cord tissue. We show 6 historical shares outstanding datapoints in our coverage of CCEL's shares outstanding history.|
Understanding the changing numbers of CCEL shares outstanding — and
comprehending the concept of differing number of shares outstanding in general comparing companies like CCEL versus peers —
is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies.
Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history.
With this page we aim to empower investors researching CCEL by allowing them to research CCEL shares outstanding history
as well as any other stock in our coverage universe.